impact factor, citescore
logo
 

Full Papers

 

Compound 78c exerts a therapeutic effect on collagen-induced arthritis and rheumatoid arthritis


1, 2, 3, 4, 5, 6, 7

 

  1. Medical Research Center of The Affiliated Hospital of Qingdao University, Shandong, China.
  2. Clinical Laboratory of Qilu Hospital, Shandong University, Shandong, China.
  3. Medical Research Center of The Affiliated Hospital of Qingdao University, Shandong, China.
  4. Medical Research Center of The Affiliated Hospital of Qingdao University, Shandong, China.
  5. Medical Research Center of The Affiliated Hospital of Qingdao University, Shandong, China.
  6. Clinical Laboratory of The Affiliated Hospital of Qingdao University, Shandong, China.
  7. Medical Research Center of The Affiliated Hospital of Qingdao University, Shandong, China. changxt@126.com

CER15849
2023 Vol.41, N°7
PI 1384, PF 1395
Full Papers

purchase article

PMID: 36377573 [PubMed]

Received: 14/05/2022
Accepted : 29/09/2022
In Press: 29/10/2022
Published: 10/07/2023

Abstract

OBJECTIVES:
Many studies have found that CD38 expression is increased in rheumatoid arthritis (RA), an autoimmune disease in which immune tolerance is dysregulated. Inhibition of CD38 expression or activity can significantly alleviate collagen-induced arthritis (CIA), a well-known animal model used for the study of RA. This study aimed to confirm the therapeutic effect of 78c, a specific inhibitor of CD38, and the role of CD38+ NK cells in immune imbalance in RA.
METHODS:
CIA mice were injected with 78c to observe the therapeutic effect. CD38+ NK cells were extracted from human peripheral blood and treated with 78c. The pretreated NK cells were co-cultured with CD4+ T cells.
RESULTS:
We found that 78c significantly suppressed joint inflammation; reduced the levels of B cells, IL-6 and TNF-α; and increased the levels of IL-10, energy metabolism and spontaneous movement in CIA mice. 78c treatment also increased Treg cell numbers and decreased the Th1/Th2 ratio in the CIA model animals. Moreover, the proportion of CD38+ NK cells was increased in the CIA mice and significantly decreased following 78c treatment. Human CD4+ T cells that were co-cultured with 78c-pretreated CD38+ NK cells differentiated into more Treg cells and had lower Th17/Treg and Th1/Th2 ratios than CD4+ T cells co-cultured with CD38+ NK cells without the pretreatment. Transcriptomic analyses demonstrated that 78c changed expression pro les in CD38+ NK cells.
CONCLUSIONS:
These results suggested that 78c could be used for the treatment of RA and CIA as it alleviates the inhibitory effect of CD38+ NK cells on CD4+ T cell differentiation to Treg cells to restore immune balance.

DOI: https://doi.org/10.55563/clinexprheumatol/0dck3t

Rheumatology Article

Rheumatology Addendum